Literature DB >> 8413942

Neurologic function in the optimally healthy oldest old. Neuropsychological evaluation.

D B Howieson1, L A Holm, J A Kaye, B S Oken, J Howieson.   

Abstract

We examined cognition on a wide range of standardized neuropsychological tests in two groups of optimally healthy, elderly volunteers. One was composed of community-dwelling, functionally independent individuals aged 84 years and older, and the other group was nearly 20 years younger. The effect of aging was greatest on visual perceptual and constructional tasks rather than on memory tasks. Many cognitive functions were relatively well preserved in the optimally healthy oldest old.

Mesh:

Year:  1993        PMID: 8413942     DOI: 10.1212/wnl.43.10.1882

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  26 in total

Review 1.  The role of ovarian hormones in preserving cognition in aging.

Authors:  Jeri S Janowsky
Journal:  Curr Psychiatry Rep       Date:  2002-12       Impact factor: 5.285

Review 2.  Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1.

Authors:  Richard Mayeux; Christiane Reitz; Adam M Brickman; Mary N Haan; Jennifer J Manly; M Maria Glymour; Christopher C Weiss; Kristine Yaffe; Laura Middleton; Hugh C Hendrie; Lauren H Warren; Kathleen M Hayden; Kathleen A Welsh-Bohmer; John C S Breitner; John C Morris
Journal:  Alzheimers Dement       Date:  2011-01       Impact factor: 21.566

3.  A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype.

Authors:  H Payami; H Grimslid; B Oken; R Camicioli; G Sexton; A Dame; D Howieson; J Kaye
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

Review 4.  Is Alzheimer's disease inevitable with age?: Lessons from clinicopathologic studies of healthy aging and very mild alzheimer's disease.

Authors:  J C Morris
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

5.  Factors associated with resistance to dementia despite high Alzheimer disease pathology.

Authors:  D Erten-Lyons; R L Woltjer; H Dodge; R Nixon; R Vorobik; J F Calvert; M Leahy; T Montine; J Kaye
Journal:  Neurology       Date:  2009-01-27       Impact factor: 9.910

Review 6.  Normal cognitive aging.

Authors:  Caroline N Harada; Marissa C Natelson Love; Kristen L Triebel
Journal:  Clin Geriatr Med       Date:  2013-11       Impact factor: 3.076

7.  Surgery is associated with ventricular enlargement as well as cognitive and functional decline.

Authors:  Katie J Schenning; Charles F Murchison; Nora C Mattek; Lisa C Silbert; Jeffrey A Kaye; Joseph F Quinn
Journal:  Alzheimers Dement       Date:  2015-11-25       Impact factor: 21.566

8.  3alpha-androstanediol, but not testosterone, attenuates age-related decrements in cognitive, anxiety, and depressive behavior of male rats.

Authors:  Cheryl A Frye; Kassandra L Edinger; Edwin D Lephart; Alicia A Walf
Journal:  Front Aging Neurosci       Date:  2010-04-08       Impact factor: 5.750

9.  Cognition is not modified by large but temporary changes in sex hormones in men.

Authors:  Laura A Young; Michelle B Neiss; Mary H Samuels; Charles E Roselli; Jeri S Janowsky
Journal:  J Clin Endocrinol Metab       Date:  2009-10-30       Impact factor: 5.958

10.  The FAS gene, brain volume, and disease progression in Alzheimer's disease.

Authors:  Deniz Erten-Lyons; Anne Jacobson; Patricia Kramer; Andrew Grupe; Jeffrey Kaye
Journal:  Alzheimers Dement       Date:  2009-09-18       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.